Related Experiment Video
Updated: May 24, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases
Rosella Tomanin1, Alessandra Zanetti, Eva Zaccariotto
1Gene Therapy Laboratory, Department of Pediatrics, University of Padova, Italy.
Unlabelled:
This review describes the different gene therapy technologies applied to approach lysosomal storage disorders, monogenic conditions, with known genetic and biochemical defects, for many of which animal models are available. Both viral and nonviral procedures are described, underlying the specific needs that the treatment of genetic disorders requires.
Conclusions:
Lysosomal storage disorders represent a good model of study of gene therapeutic procedures that are, or could be, relevant to the treatment of several other mendelian diseases.
More Related Videos
09:54Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Related Concept Videos
Lysosomal Hydrolases
Gene Therapy
Gene Therapy
Pharmacogenomics: Identification of New Drug Targets
Incomplete Dominance
Microorganisms in Medicine and Therapeutics